Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. Bekker LG, Das M, Abdool Karim Q, Ahmed K, et al. N Engl J Med 2024 Jul 24. doi: 10.1056/NEJMoa2407001.

Read + Share

Amedeo Smart

Independent Medical Education

Bekker LG, Das M, Abdool Karim Q, Ahmed K, et al. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. N Engl J Med 2024 Jul 24. doi: 10.1056/NEJMoa2407001.
PMID: 39046157